Standard
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma. / Urup, Thomas; Gillberg, Linn; Kaastrup, Katja; Lü, Maya Jeje Schuang; Michaelsen, Signe Regner; Andrée Larsen, Vibeke; Christensen, Ib Jarle; Broholm, Helle; Lassen, Ulrik; Grønbæk, Kirsten; Poulsen, Hans Skovgaard.
I:
Molecular Oncology, Bind 14, Nr. 5, 2020, s. 964-973.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Urup, T
, Gillberg, L, Kaastrup, K, Lü, MJS
, Michaelsen, SR, Andrée Larsen, V, Christensen, IJ, Broholm, H
, Lassen, U, Grønbæk, K & Poulsen, HS 2020, '
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma',
Molecular Oncology, bind 14, nr. 5, s. 964-973.
https://doi.org/10.1002/1878-0261.12660APA
Urup, T.
, Gillberg, L., Kaastrup, K., Lü, M. J. S.
, Michaelsen, S. R., Andrée Larsen, V., Christensen, I. J., Broholm, H.
, Lassen, U., Grønbæk, K., & Poulsen, H. S. (2020).
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.
Molecular Oncology,
14(5), 964-973.
https://doi.org/10.1002/1878-0261.12660Vancouver
Urup T
, Gillberg L, Kaastrup K, Lü MJS
, Michaelsen SR, Andrée Larsen V o.a.
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.
Molecular Oncology. 2020;14(5):964-973.
https://doi.org/10.1002/1878-0261.12660Author
Urup, Thomas ; Gillberg, Linn ; Kaastrup, Katja ; Lü, Maya Jeje Schuang ; Michaelsen, Signe Regner ; Andrée Larsen, Vibeke ; Christensen, Ib Jarle ; Broholm, Helle ; Lassen, Ulrik ; Grønbæk, Kirsten ; Poulsen, Hans Skovgaard. / Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma. I: Molecular Oncology. 2020 ; Bind 14, Nr. 5. s. 964-973.
Bibtex
@article{3098d5be935b4c84b39093f16eddb4fa,
title = "Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma",
author = "Thomas Urup and Linn Gillberg and Katja Kaastrup and L{\"u}, {Maya Jeje Schuang} and Michaelsen, {Signe Regner} and {Andr{\'e}e Larsen}, Vibeke and Christensen, {Ib Jarle} and Helle Broholm and Ulrik Lassen and Kirsten Gr{\o}nb{\ae}k and Poulsen, {Hans Skovgaard}",
year = "2020",
doi = "10.1002/1878-0261.12660",
language = "English",
volume = "14",
pages = "964--973",
journal = "Molecular Oncology",
issn = "1574-7891",
publisher = "Elsevier",
number = "5",
}
RIS
TY - JOUR
T1 - Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
AU - Urup, Thomas
AU - Gillberg, Linn
AU - Kaastrup, Katja
AU - Lü, Maya Jeje Schuang
AU - Michaelsen, Signe Regner
AU - Andrée Larsen, Vibeke
AU - Christensen, Ib Jarle
AU - Broholm, Helle
AU - Lassen, Ulrik
AU - Grønbæk, Kirsten
AU - Poulsen, Hans Skovgaard
PY - 2020
Y1 - 2020
U2 - 10.1002/1878-0261.12660
DO - 10.1002/1878-0261.12660
M3 - Journal article
C2 - 32133779
VL - 14
SP - 964
EP - 973
JO - Molecular Oncology
JF - Molecular Oncology
SN - 1574-7891
IS - 5
ER -
